Mozart Therapeutics
Mozart Therapeutics develops therapies for celiac disease and other immune-related conditions.
Facts
- HQ
- Seattle, Washington, USA
- Sectors
- Biotechnology, Biopharma, Immunology
- Founded
- 2023
- Type
- Corporation Seattle business license
- Registered name
- Mozart Therapeutics Inc Seattle business license
- Stage
- Series C
Is this your organization? Claim it
Members see Mozart Therapeutics's funding rounds, amounts and investors.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
Katie Fanning Executive, President and Chief Executive Officer